|
FOXO3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.827000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.013610E-01 |
| Normal-vs-Stage2 |
4.200200E-01 |
| Normal-vs-Stage3 |
7.338400E-01 |
| Normal-vs-Stage4 |
8.139000E-01 |
| Stage1-vs-Stage2 |
5.858600E-01 |
| Stage1-vs-Stage3 |
1.230450E-01 |
| Stage1-vs-Stage4 |
4.566200E-01 |
| Stage2-vs-Stage3 |
3.265200E-01 |
| Stage2-vs-Stage4 |
7.505600E-01 |
| Stage3-vs-Stage4 |
6.942600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.132200E-01 |
| Normal-vs-AfricanAmerican |
2.985400E-01 |
| Normal-vs-Asian |
1.651370E-01 |
| Caucasian-vs-AfricanAmerican |
6.396800E-01 |
| Caucasian-vs-Asian |
3.540800E-01 |
| AfricanAmerican-vs-Asian |
3.300400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.621000E-01 |
| Normal-vs-Female |
7.359000E-01 |
| Male-vs-Female |
3.745900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.229400E-01 |
| Normal-vs-Extreme_Weight |
4.309900E-02 |
| Normal-vs-Obese |
4.735400E-01 |
| Normal-vs-Extreme_Obese |
1.399240E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.340200E-01 |
| Normal_Weight-vs-Obese |
4.200300E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.882600E-01 |
| Extreme_Weight-vs-Obese |
2.301900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.988800E-01 |
| Obese-vs-Extreme_Obese |
1.014620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.843800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.270200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.326500E-02 |
| Normal-vs-Age(81-100Yrs) |
9.774400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.113200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.395020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.544410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.557930E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.956310E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.566800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.057200E-01 |
| Normal-VS-Type2 PRCC |
2.022400E-02 |
| Normal-VS-KIRP CIMP |
1.775560E-01 |
| Normal-VS-Unclassified PRCC |
9.722600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.862200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.492600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.317200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.042000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.505900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.016200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.584700E-03 |
| Normal-vs-N1 |
2.328800E-01 |
| Normal-vs-N2 |
5.801200E-01 |
| N0-vs-N1 |
1.087680E-02 |
| N0-vs-N2 |
5.203800E-01 |
| N1-vs-N2 |
7.247800E-02 |
|
|
